DocMode Health Technologies Limited (NSE:DHTL)
India · Delayed Price · Currency is INR 29.40
-1.50 (-4.85%)
Sep 16, 2026, 10:36 AM IST
NSE:DHTL Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 92 | 127 | 156 | 672 | - | - | |
Market Cap Growth | -28.29% | -18.18% | -76.84% | - | - | - |
Enterprise Value | 127 | 194 | 226 | 737 | - | - |
Last Close Price | 29.40 | 40.50 | 49.50 | 213.70 | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | - | 358.00 | - | - |
PS Ratio | 0.36 | 0.50 | 0.37 | 1.68 | - | - |
PB Ratio | 1.12 | 1.55 | 1.86 | 6.47 | - | - |
P/TBV Ratio | - | - | - | 36.12 | - | - |
P/FCF Ratio | 3.82 | 5.26 | 5.13 | - | - | - |
P/OCF Ratio | 2.15 | 2.96 | 2.33 | 14.90 | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.50 | 0.76 | 0.54 | 1.84 | - | - |
EV/EBITDA Ratio | 12.00 | 18.35 | 245.96 | 39.42 | - | - |
EV/EBIT Ratio | 15.43 | 23.58 | - | 39.63 | - | - |
EV/FCF Ratio | 5.25 | 8.03 | 7.46 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.45 | 0.45 | 0.82 | 0.89 | 2.44 | 3.49 |
Debt / EBITDA Ratio | 3.52 | 3.52 | 74.17 | 4.91 | 2.27 | 2.57 |
Debt / FCF Ratio | 1.54 | 1.54 | 2.25 | - | - | - |
Net Debt / Equity Ratio | 0.42 | 0.42 | 0.59 | 0.57 | 2.30 | 3.28 |
Net Debt / EBITDA Ratio | 3.27 | 3.27 | 53.28 | 3.16 | 2.14 | 2.42 |
Net Debt / FCF Ratio | 1.43 | 1.43 | 1.62 | -2.03 | -3.29 | -1.88 |
Asset Turnover | 0.70 | 0.70 | 1.20 | 1.70 | 2.43 | 1.58 |
Inventory Turnover | 2.11 | 2.11 | 5.28 | 12.45 | 0.37 | 0.63 |
Quick Ratio | 0.33 | 0.33 | 0.38 | 1.00 | 1.02 | 0.83 |
Current Ratio | 0.73 | 0.73 | 0.85 | 1.31 | 1.58 | 1.69 |
Return on Equity (ROE) | -1.63% | -1.63% | -21.65% | 2.71% | 80.13% | 99.55% |
Return on Assets (ROA) | 1.41% | 1.41% | -0.36% | 4.93% | 17.18% | 14.77% |
Return on Invested Capital (ROIC) | 7.05% | 6.60% | -1.35% | 7.41% | 30.98% | 32.45% |
Return on Capital Employed (ROCE) | 8.30% | 8.30% | -2.00% | 12.10% | 44.40% | 36.30% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -1.46% | -1.06% | -13.03% | 0.28% | - | - |
FCF Yield | 26.17% | 19.00% | 19.51% | -4.33% | - | - |
Buyback Yield / Dilution | 0.18% | 0.18% | - | -37.07% | -30.43% | - |